No Data
No Data
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Tech firms were leading European equities traded in the US as American depositary receipts moderately higher late Thursday morning, rising 0.50% to 1,448.39 on the S&P Europe Select ADR Index. From co
Jefferies Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $56
Jefferies analyst Kelly Shi maintains $Bicycle Therapeutics(BCYC.US)$ with a buy rating, and adjusts the target price from $59 to $56.According to TipRanks data, the analyst has a success rate of 30.4
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were moving sharply lower Wednesday morning, falling 1.39% to 1,402.95 on the S&P Europe Select ADR Index. Gainers in continental Eur
Bicycle Therapeutics (NASDAQ:BCYC) Delivers Shareholders Solid 16% CAGR Over 5 Years, Surging 6.1% in the Last Week Alone
It hasn't been the best quarter for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, since the share price has fallen 12% in that time. But that scarcely detracts from the really solid long ter